Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study
about
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationDrugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksAssociation of Prenatal Ibuprofen Exposure with Birth Weight and Gestational Age: A Population-Based Sibling StudyAuricular acupuncture for primary care treatment of low back pain and posterior pelvic pain in pregnancy: study protocol for a multicentre randomised placebo-controlled trialCase-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant StudyPregnant women and non-steroidal anti-inflammatory drugs: knowledge, perception and drug consumption pattern during pregnancy in ethiopiaAcetylsalicylic acid interferes with embryonic kidney growth and development by a prostaglandin-independent mechanism.Nongenetic risk factors and congenital heart defects.High-risk pregnancy and the rheumatologist.Genetic and nongenetic etiology of nonsyndromic anorectal malformations: a systematic review.Maternal flu or fever, medications use in the first trimester and the risk for neural tube defects: a hospital-based case-control study in China.Pharmacological treatment of migraine during pregnancy and breastfeeding.Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study.Migraine Treatment in Pregnancy and Lactation.Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis.
P2860
Q26765038-03811C9E-4811-41A9-97F0-F64325AF0E26Q26991704-4B54288E-3AD3-456D-8866-98070606E56AQ28554873-7FC74DEC-B904-467C-96C1-2844908D896EQ34468560-615C4C28-6490-4138-A2A3-FDB3FDFEB02DQ35525008-A19002B1-13D9-4B9F-AF49-0C17E67052D8Q35811049-E476717D-06AA-4682-82A8-01BCD600D98DQ37560421-10E8E002-31C5-46B1-919E-8EABA1B9B33FQ38130429-130F40BB-31BB-448A-88AA-B9151C88C27CQ38283472-A61980E2-6CD8-4768-BE4B-48E5F26FE0C8Q38302647-B2578124-C5F5-4003-B7FE-30B063203F0BQ40230515-1F10B47D-9903-4152-A3A9-7F01CDD91C0BQ43063871-75AD80F7-DC46-40DF-8387-C77D5D8426E9Q47353855-580C4AC3-25CE-4C98-9FC2-632265EA6371Q47619378-6E056339-3933-44DD-9AAE-7612820BED1CQ55313592-FD972004-1B23-4B10-9DFE-4AC07863A954
P2860
Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exposure to non-steroidal anti ...... ts: a prospective cohort study
@ast
Exposure to non-steroidal anti ...... ts: a prospective cohort study
@en
type
label
Exposure to non-steroidal anti ...... ts: a prospective cohort study
@ast
Exposure to non-steroidal anti ...... ts: a prospective cohort study
@en
prefLabel
Exposure to non-steroidal anti ...... ts: a prospective cohort study
@ast
Exposure to non-steroidal anti ...... ts: a prospective cohort study
@en
P2860
P1433
P1476
Exposure to non-steroidal anti ...... ts: a prospective cohort study
@en
P2093
Marleen M H J van Gelder
Nel Roeleveld
P2860
P304
P356
10.1371/JOURNAL.PONE.0022174
P407
P577
2011-07-18T00:00:00Z